.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Relapsed or Refractory Metastatic CRC

EP. 1: Continuum of Care in Metastatic Colorectal Cancer

February 25th 2020

EP. 2: Initial Systemic Therapy for Metastatic Colorectal Cancer

February 25th 2020

EP. 3: Molecular Status and Subsequent Therapies in mCRC

February 25th 2020

EP. 4: Role of Rebiopsy and ctDNA Testing at Progression of mCRC

February 25th 2020

EP. 5: Third-line and Later-line Therapies in R/R mCRC

February 25th 2020

EP. 6: R/R Metastatic CRC: CORRECT, IMblaze370, and ReDOS Trials

February 25th 2020

EP. 7: Management of R/R mCRC: Sequencing for Later-Line Therapies

February 25th 2020

EP. 8: Relapsed/Refractory mCRC: Immunotherapy in MSI-High Tumors

February 25th 2020

EP. 9: Role of Immunotherapy in Microsatellite-Stable R/R mCRC

February 25th 2020

EP. 10: Future Directions for Later-Line Therapy in R/R mCRC

February 25th 2020